BioTech/Drugs - Atlanta, GA, US
Odylia utilizes a unique, nonprofit business model to accelerate the development of gene therapies for people with rare disease. Our ultimate goal is to bring life changing treatments to people with genetic disease, regardless of prevalence or commercial interest.
Gmail
Apache
WordPress.org
Google Tag Manager
Mobile Friendly